Charles Rhyee
Stock Analyst at TD Cowen
(4.28)
# 1,370
Out of 4,509 analysts
653
Total ratings
53%
Success rate
6%
Average return
Main Sectors:
Stocks Rated by Charles Rhyee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CAH Cardinal Health | Maintained: Buy | $255 → $275 | $233.66 | +17.69% | 39 | Jul 9, 2026 | |
| ICLR ICON Public Limited Company | Rated: Buy | $164 → $197 | $166.10 | +18.60% | 20 | Jun 24, 2026 | |
| MCK McKesson | Maintained: Buy | $1,012 | $812.28 | +24.59% | 49 | Jun 18, 2026 | |
| BTSG BrightSpring Health Services | Rated: Buy | $65 → $81 | $69.64 | +16.31% | 11 | Jun 18, 2026 | |
| CRL Charles River Laboratories International | Reiterated: Buy | $235 | $229.75 | +2.29% | 22 | Jun 4, 2026 | |
| VEEV Veeva Systems | Maintained: Buy | $300 → $235 | $196.81 | +19.40% | 20 | Jun 4, 2026 | |
| COR Cencora | Rated: Buy | $400 | $306.13 | +30.66% | 50 | Jun 1, 2026 | |
| MDRX Veradigm Inc. | Reiterated: Buy | $8 | $4.75 | +68.42% | 21 | May 27, 2026 | |
| DRIO DarioHealth | Maintained: Hold | $11 | $6.70 | +64.18% | 17 | May 13, 2026 | |
| CVS CVS Health | Reiterated: Buy | $105 → $110 | $105.90 | +3.87% | 58 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 → $8 | $5.92 | +35.14% | 48 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $3 → $4 | $3.04 | +31.58% | 36 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $53 | $40.58 | +30.61% | 4 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $5 → $8 | $11.01 | -27.34% | 20 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $213 | $207.55 | +2.63% | 24 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $15 → $18 | $17.86 | +0.78% | 15 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $338 | $304.50 | +11.00% | 18 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $6 | $9.65 | -37.82% | 58 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $23.03 | +82.37% | 9 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $37 → $23 | $21.70 | +5.99% | 6 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $419 | $530.19 | -20.97% | 14 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 → $9 | $5.23 | +72.08% | 19 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $6.40 | +134.38% | 21 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $90 | $29.91 | n/a | 1 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $51 | $86.37 | n/a | 1 | Jun 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $14.96 | n/a | 1 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $170 | $182.20 | n/a | 1 | Oct 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.0001 | n/a | 3 | Dec 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2 → $250 | $0.0001 | n/a | 6 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $9 → $1.3 | $0.0001 | n/a | 8 | May 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $370 → $415 | $429.09 | n/a | 6 | Apr 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $360 → $395 | $425.17 | n/a | 5 | Apr 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $29 | $31.60 | n/a | 1 | Mar 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $74 → $80 | $68.29 | n/a | 4 | Feb 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $410 → $460 | $406.00 | n/a | 7 | Feb 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $200 → $210 | $242.88 | n/a | 5 | Jun 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $30 → $29 | $46.68 | n/a | 4 | Oct 30, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $42 | $20.37 | n/a | 1 | Feb 25, 2014 |
Cardinal Health
Jul 9, 2026
Maintained: Buy
Price Target: $255 → $275
Current: $233.66
Upside: +17.69%
ICON Public Limited Company
Jun 24, 2026
Rated: Buy
Price Target: $164 → $197
Current: $166.10
Upside: +18.60%
McKesson
Jun 18, 2026
Maintained: Buy
Price Target: $1,012
Current: $812.28
Upside: +24.59%
BrightSpring Health Services
Jun 18, 2026
Rated: Buy
Price Target: $65 → $81
Current: $69.64
Upside: +16.31%
Charles River Laboratories International
Jun 4, 2026
Reiterated: Buy
Price Target: $235
Current: $229.75
Upside: +2.29%
Veeva Systems
Jun 4, 2026
Maintained: Buy
Price Target: $300 → $235
Current: $196.81
Upside: +19.40%
Cencora
Jun 1, 2026
Rated: Buy
Price Target: $400
Current: $306.13
Upside: +30.66%
Veradigm Inc.
May 27, 2026
Reiterated: Buy
Price Target: $8
Current: $4.75
Upside: +68.42%
DarioHealth
May 13, 2026
Maintained: Hold
Price Target: $11
Current: $6.70
Upside: +64.18%
CVS Health
May 11, 2026
Reiterated: Buy
Price Target: $105 → $110
Current: $105.90
Upside: +3.87%
May 11, 2026
Maintained: Buy
Price Target: $7 → $8
Current: $5.92
Upside: +35.14%
May 11, 2026
Rated: Buy
Price Target: $3 → $4
Current: $3.04
Upside: +31.58%
May 7, 2026
Maintained: Buy
Price Target: $53
Current: $40.58
Upside: +30.61%
May 6, 2026
Rated: Hold
Price Target: $5 → $8
Current: $11.01
Upside: -27.34%
May 5, 2026
Maintained: Buy
Price Target: $213
Current: $207.55
Upside: +2.63%
May 5, 2026
Rated: Buy
Price Target: $15 → $18
Current: $17.86
Upside: +0.78%
May 4, 2026
Rated: Buy
Price Target: $338
Current: $304.50
Upside: +11.00%
May 4, 2026
Rated: Hold
Price Target: $6
Current: $9.65
Upside: -37.82%
May 4, 2026
Reiterated: Buy
Price Target: $42
Current: $23.03
Upside: +82.37%
Apr 30, 2026
Rated: Hold
Price Target: $37 → $23
Current: $21.70
Upside: +5.99%
Apr 23, 2026
Maintained: Hold
Price Target: $419
Current: $530.19
Upside: -20.97%
Feb 20, 2026
Maintained: Buy
Price Target: $6 → $9
Current: $5.23
Upside: +72.08%
Nov 13, 2025
Maintained: Buy
Price Target: $15
Current: $6.40
Upside: +134.38%
Jun 11, 2025
Reiterated: Buy
Price Target: $90
Current: $29.91
Upside: n/a
Jun 5, 2025
Initiated Coverage: Buy
Price Target: $51
Current: $86.37
Upside: n/a
Sep 9, 2024
Reiterated: Buy
Price Target: n/a
Current: $14.96
Upside: n/a
Oct 30, 2023
Maintained: Buy
Price Target: $170
Current: $182.20
Upside: n/a
Dec 12, 2022
Reiterated: Buy
Price Target: n/a
Current: $0.0001
Upside: n/a
Aug 16, 2022
Maintained: Buy
Price Target: $2 → $250
Current: $0.0001
Upside: n/a
May 17, 2022
Maintained: Sell
Price Target: $9 → $1.3
Current: $0.0001
Upside: n/a
Apr 16, 2021
Maintained: Buy
Price Target: $370 → $415
Current: $429.09
Upside: n/a
Apr 14, 2021
Maintained: Buy
Price Target: $360 → $395
Current: $425.17
Upside: n/a
Mar 29, 2021
Initiated Coverage: Hold
Price Target: $29
Current: $31.60
Upside: n/a
Feb 8, 2021
Maintained: Buy
Price Target: $74 → $80
Current: $68.29
Upside: n/a
Feb 1, 2021
Maintained: Hold
Price Target: $410 → $460
Current: $406.00
Upside: n/a
Jun 16, 2020
Upgraded: Buy
Price Target: $200 → $210
Current: $242.88
Upside: n/a
Oct 30, 2015
Maintained: Hold
Price Target: $30 → $29
Current: $46.68
Upside: n/a
Feb 25, 2014
Initiated Coverage: Buy
Price Target: $42
Current: $20.37
Upside: n/a